Epidemiological studies have shown or suggested ethnic differences in SLE prevalence rates. Studies in New York City,' San Francisco,2 and Jefferson County, Alabama,3 have shown a 2-4 to 3-3 times higher prevalence of the disease in blacks than in whites. Hospital based studies in West Malaysia4 and Singapore5 have suggested a greater prevalence in orientals. A similar high prevalence rate has been claimed for blacks in Jamaica,6 and a recent study from Hawaii7 has shown rates for orientals and Polynesians 3 to 4 times that for whites.
Ethnic differences in mortality rates from systemic lupus erythematosus have also been found. In the United States8 from 1968 to 1972 the rates for white and black females were 5 2 and 14*8 per million person years respectively. The overall rate for blacks was 2 The prevalence of SLE was estimated by counting all patients found and subtracting deaths occurring during the period. These figures were related to the population estimates derived from the 1976 National Census. Age-specific mortality rates for SLE were calculated from the white population as standard. The significance of the difference between groups was determined.'2 Survival curves were constructed for both ethnic groups. '3 
Results
One hundred and fifty-one patients with SLE were identified by the criteria of Fries and Holman."0 There were 15 deaths, leaving 136, including 96 patients with 4 or more ARA criteria. Females predominated, making up 123 of the remaining 136 patients. Although whites constitute 83% of the Auckland population, only 71 % of the definite cases of SLE were from this group. The incidence of lupus manifestations for Polynesians, whites, and all Auckland cases was compared with those in a series of mixed race compiled by rheumatologists" ( Table 2) . Symptoms which may not be volunteered by the patient and which may require specific questions to discover, such as photosensitivity, alopecia, and pleuritis, were less frequently recorded, but this is to be expected in a retrospective study. Similarly manifestations requiring special skills for their detection, such as discoid lupus, arthritis, and urinary casts, were also less frequent than in the reference series. Notable ethnic differences were the lower incidence of Raynaud's phenomenon, photosensitivity, and arthritis in the Polynesian group and a higher incidence of chronically false positive VDRL (Venereal Disease Reference Laboratories test), haemolytic anaemia and thrombocytopenia. Psychosis was lower in all groups, probably because the retrospective differentiation of cerebral lupus from steroid psychosis and reactive depression was extremely difficult. None of these differences was statistically significant (Table 3 ).
The prevalence rates estimated for the end of 1980 are shown in Table 4 . The overall rate for Auckland was 18 per 100 000, with rates for women aged 15 to The figure in parentheses represents the total number of patients and the figure below the number fulfilling fewer than 4 ARA criteria.
group.bmj.com on June 22, 2017 -Published by http://ard.bmj.com/ Downloaded from Ethnic difference in the prevalence ofsystemic lupus erythematosus 531 (Table 4) . Age-specific mortality rates for SLE were calculated from the white population as standard. This procedure showed the rate for Polynesians to be 13 0 and whites 2*5 per million person years. Survival curves were constructed which showed the Polynesian 6-year survival to be 87% and whites 96%. This difference was not significant (log rank test), suggesting that there is no difference in the severity of the disease in the 2 populations.
Discussion
A study from San Francisco2 of members of a prepaid health plan that cares for 125 000 people showed the prevalence of definite SLE to be 51 per 100 000. The rate for women aged 15 to 64 years was 142 per 100 000 and in black women in the same age group 408 per 100 000. It should be noted that in this study the investigators had access to complete medical records. Similar ethnic differences have been confirmed by other studies, but the prevalence rates have been considerably lower. This is particularly true of those based on hospital records, for this method undoubtedly leads to the exclusion of many milder cases. In a study from Hawaii,7 for example, the rates for whites was 5 -8 per 100 000 compared with 20 per 100 000 for Chinese, Philipinos, and Polynesians.
Our study suggests that in Auckland SLE is also substantially more common among people of black (Polynesian) ancestry. The overall prevalence rates lie somewhere between the 2 studies mentioned above, which is in keeping with our method of finding patients. Inevitably some cases in the community will have been missed, particularly in a retrospective survey.
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